The recall was initiated due to a risk of metal contamination that could potentially injure a patient. At this time, however, no adverse events have been reported.
Voters in Broward County, Florida, have agreed to fund a CCTA screening program after a pilot study linked the practice to considerable benefits. "This is actually very big news and will save thousands of lives," one local imaging specialist said.
The MiniMed Fit is indicated for patients 7 years old and older with type 1 or type 2 diabetes. This represents the second FDA clearance for a tubeless automated insulin delivery system in a matter of days.
Coronary inflammation may play a critical role in the prevention and treatment of cardiovascular disease. American College of Cardiology President Roxana Mehran, MD, spoke to Cardiovascular Business about this topic at TCT 2026.
Shahab Moossavi, MD, is remembered as a "dedicated physician who made a meaningful difference in the lives of his patients and the colleagues who worked alongside him." He was 51 years old.
Remedy Robotics has developed an AI-powered robotic platform and software suite that can be used before and during endovascular procedures. The company plans on using this funding round to ramp up clinical research, deploy prototypes and more.
Patients with a Tandem Mobi insulin pump will soon be able to choose between two wear options—tubed and tubeless—with the same device. Tubeless insulin delivery can last up to seven days.
Curtiss Stinis, MD, has been performing TAVR for nearly two decades. He says the new policies from CMS that expand coverage for asymptomatic patients represent a "momentous step forward" for heart patients with severe aortic stenosis.